These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23889540)

  • 1. Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation.
    Kamada M; Izumi Y; Ayaki T; Nakamura M; Kagawa S; Kudo E; Sako W; Maruyama H; Nishida Y; Kawakami H; Ito H; Kaji R
    Neuropathology; 2014 Feb; 34(1):64-70. PubMed ID: 23889540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical heterogeneity within the ALS-FTD spectrum in a family with a homozygous optineurin mutation.
    Parvizi T; Klotz S; Keritam O; Caliskan H; Imhof S; König T; Haider L; Traub-Weidinger T; Wagner M; Brunet T; Brugger M; Zimprich A; Rath J; Stögmann E; Gelpi E; Cetin H
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1579-1589. PubMed ID: 38689506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric analysis of spinal motor neuron degeneration in sporadic amyotrophic lateral sclerosis.
    Aizawa H; Nagumo S; Hideyama T; Kato H; Kwak S; Terashi H; Suzuki Y; Kimura T
    J Neurol Sci; 2024 Sep; 464():123177. PubMed ID: 39146882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative features of sporadic amyotrophic lateral sclerosis: Motor neurons of Onuf's nucleus survive in ADAR2-conditional knockout mice.
    Hideyama T; Teramoto S; Kato H; Terashi H; Kwak S; Aizawa H
    J Neurol Sci; 2024 Aug; 463():123142. PubMed ID: 39053342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions.
    Bjelica B; Bartels MB; Hesebeck-Brinckmann J; Petri S
    J Neurol; 2024 Jul; 271(7):3953-3977. PubMed ID: 38805053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis.
    Xin J; Huang S; Wen J; Li Y; Li A; Satyanarayanan SK; Yao X; Su H
    Aging Dis; 2024 May; ():. PubMed ID: 38739934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optineurin deficiency induces patchy hair loss but it is not sufficient to cause amyotrophic lateral sclerosis in mice.
    Moharir SC; Swarup G
    Biochim Biophys Acta Mol Basis Dis; 2022 Oct; 1868(10):166470. PubMed ID: 35750266
    [No Abstract]   [Full Text] [Related]  

  • 8. Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration.
    Liu D; Webber HC; Bian F; Xu Y; Prakash M; Feng X; Yang M; Yang H; You IJ; Li L; Liu L; Liu P; Huang H; Chang CY; Liu L; Shah SH; Torre A; Welsbie DS; Sun Y; Duan X; Goldberg JL; Braun M; Lansky Z; Hu Y
    bioRxiv; 2024 Apr; ():. PubMed ID: 38617277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation.
    Wong YC; Holzbaur EL
    Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4439-48. PubMed ID: 25294927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.
    Shen WC; Li HY; Chen GC; Chern Y; Tu PH
    Autophagy; 2015 Apr; 11(4):685-700. PubMed ID: 25484089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.
    Cirulli ET; Lasseigne BN; Petrovski S; Sapp PC; Dion PA; Leblond CS; Couthouis J; Lu YF; Wang Q; Krueger BJ; Ren Z; Keebler J; Han Y; Levy SE; Boone BE; Wimbish JR; Waite LL; Jones AL; Carulli JP; Day-Williams AG; Staropoli JF; Xin WW; Chesi A; Raphael AR; McKenna-Yasek D; Cady J; Vianney de Jong JM; Kenna KP; Smith BN; Topp S; Miller J; Gkazi A; ; Al-Chalabi A; van den Berg LH; Veldink J; Silani V; Ticozzi N; Shaw CE; Baloh RH; Appel S; Simpson E; Lagier-Tourenne C; Pulst SM; Gibson S; Trojanowski JQ; Elman L; McCluskey L; Grossman M; Shneider NA; Chung WK; Ravits JM; Glass JD; Sims KB; Van Deerlin VM; Maniatis T; Hayes SD; Ordureau A; Swarup S; Landers J; Baas F; Allen AS; Bedlack RS; Harper JW; Gitler AD; Rouleau GA; Brown R; Harms MB; Cooper GM; Harris T; Myers RM; Goldstein DB
    Science; 2015 Mar; 347(6229):1436-41. PubMed ID: 25700176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
    Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
    Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of optineurin in vivo results in elevated cell death and alters axonal trafficking dynamics.
    Paulus JD; Link BA
    PLoS One; 2014; 9(10):e109922. PubMed ID: 25329564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mutations and deletions in the human optineurin gene.
    Turturro S; Shen X; Shyam R; Yue BY; Ying H
    Springerplus; 2014; 3():99. PubMed ID: 24683533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optineurin immunoreactivity in neuronal and glial intranuclear inclusions in adult-onset neuronal intranuclear inclusion disease.
    Nakamura M; Murray ME; Lin WL; Kusaka H; Dickson DW
    Am J Neurodegener Dis; 2014; 3(2):93-102. PubMed ID: 25232514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
    Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
    Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optineurin: The autophagy connection.
    Ying H; Yue BY
    Exp Eye Res; 2016 Mar; 144():73-80. PubMed ID: 26142952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
    Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
    Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis.
    Sundaramoorthy V; Walker AK; Tan V; Fifita JA; Mccann EP; Williams KL; Blair IP; Guillemin GJ; Farg MA; Atkin JD
    Hum Mol Genet; 2015 Jul; 24(13):3830-46. PubMed ID: 25859013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of play in amyotrophic lateral sclerosis genetics.
    Renton AE; Chiò A; Traynor BJ
    Nat Neurosci; 2014 Jan; 17(1):17-23. PubMed ID: 24369373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.